Risk factors
Rapport Therapeutics (RAPP) risk factors
Item 1A of every Rapport Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors105 risks8 new3 dropped18 reworded
Rapport Therapeutics added comprehensive privacy and data security risk disclosures reflecting complex state and international regulations.
Filed Mar 10, 2026 - FY2024 10-K risk factors100 risks
Rapport Therapeutics faces high capital requirements and clinical trial execution risks for its nervous system drug candidates.
Filed Mar 11, 2025